Skip to content

Investigation of Neurocognitive Measures of Sport-Related Injury

Investigation of Neurocognitive Measures of Sport-Related Injury

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03414242
Enrollment
4000
Registered
2018-01-29
Start date
2019-03-12
Completion date
2028-12-01
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concussion, Brain

Keywords

brain, concussion, neck, strength, sport, prevention

Brief summary

The overall objective is to provide an onsite diagnosis with subsequent return to play criteria, as well as, lower the risk of traumatic brain injury by primary prevention through cervical spine neuromuscular control and vision training. The central hypothesis is that improved understanding of neurocognitive measures and function will provide improved diagnosis of concussion and help reduce the incidence of subsequent sports-related injury.

Interventions

OTHERCervical spine musculature

Previously established cervical spine musculature training methodology will be utilized to develop a concussion prevention training program.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* 12-30 year old competitive or recreational athletes

Exclusion criteria

* Pre-existing condition preventing the ability to perform neck range of motion or a neck strength assessment * Recent exposure to head lice * Known or suspected pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in blood metabolite profileThrough study completion, an athletic season average of 4 monthsBlood metabolite profile change from baseline blood draws will be analyzed to determine what blood biomarkers (e.g. amino acids, glycerophospholipids (mg/dL) ) are most sensitive to the presence of a concussion.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid Soma, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026